ArticleFrontiers in oncology2022

Association of HER-2/CEP17 Ratio and HER-2 Copy Number With pCR Rate in HER-2-Positive Breast Cancer After Dual-Target Neoadjuvant Therapy With Trastuzumab and Pertuzumab.

Fanfan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.